NCOA3 and breast carcinoma: Length of repeat variations in the androgen receptor gene and in the steroid nuclear receptor coactivator AIB1/NCOA3 were reported to affect breast cancer risk (reviewed in Narod, 2002a), but this has not been confirmed (Spurdle et al, 2005, 2006).